Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, ottobre 27
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
United Therapeutics Corp
UTHR
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$592.84
5.34
0.91%
Ult. Agg.: Oct 26, 7:49 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 8 giorni da adesso in mer nov 4th, prima dell'apertura del mercato
United Therapeutics Financials
United Therapeutics (UTHR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow Jones Futures Gain as Investors Await September Inflation Report— ASML, GME, UNH in Focus
U.S. stock futures were higher on Wednesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Tuesday's lower close.
Rishabh Mishra
PRO
United Therapeutics Q2 EPS $7.27 Beats $6.88 Estimate, Sales $783.300M Miss $805.645M Estimate
Benzinga Newsdesk
Baidu, Brady And 3 Stocks To Watch Heading Into Monday
U.S. stock futures down on Monday. Focus on Baidu, Brady, United Therapeutics for earnings. XP and Ryanair to report after markets close.
Avi Kapoor
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
United Therapeutics Q1 EPS $5.82 Misses $6.92 Estimate, Sales $781.500M Miss $796.921M Estimate
United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $5.82 per share which missed the analyst consensus estimate of $6.92 by 15.9 percent. This is a 12.22 percent decrease over earnings of $6.63 per share
Benzinga Newsdesk
These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings
Avi Kapoor
